CXCR6 has been identified as a preferentially expressed chemokine receptor on CD8+ TRM cells following vaccination in murine models, as well as on intratumoral CD8+ TRM cells isolated from human lung cancer specimens. The gene discussed is CD8A; the disease is lung carcinoma.